SEC Form SC 13G/A filed by Surgery Partners Inc. (Amendment)
$SGRY
Hospital/Nursing Management
Health Care
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 9/18/2025 | $27.00 | Neutral | Analyst |
| 7/28/2025 | $28.00 | Buy | BofA Securities |
| 12/16/2024 | $30.00 | Buy | BofA Securities |
| 10/14/2024 | $38.00 | Buy | UBS |
| 10/11/2024 | Sector Weight | KeyBanc Capital Markets | |
| 6/28/2024 | $31.00 | Outperform | Macquarie |
| 3/6/2024 | $35.00 | Equal Weight | Barclays |
| 11/14/2023 | $39.00 → $35.00 | Market Perform → Outperform | TD Cowen |
4 - Surgery Partners, Inc. (0001638833) (Issuer)
4 - Surgery Partners, Inc. (0001638833) (Issuer)
4 - Surgery Partners, Inc. (0001638833) (Issuer)
BRENTWOOD, Tenn., March 12, 2026 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company") recently announced that Lloyd Dean has been appointed to serve as an independent director on its Board of Directors. Mr. Dean is the former Chief Executive Officer of CommonSpirit Health, one of the largest nonprofit health systems in the United States, with 142 hospitals, over 1,000 care sites, 25,000 physicians, and 150,000 employees across 21 states. From 2019 to 2022, he led the formation and integration of CommonSpirit, advancing clinical quality, operational performance, and community health initiatives at national scale. Prior to CommonSpirit, Mr. Dean ser
Surgery Board and Management Team Have Presided Over the Vast Destruction of Value and Must Be Held Accountable Letter Outlines Multiple Paths to Building and Unlocking Intrinsic Value for Stockholders Divestiture of Surgical Hospitals Should Generate Billions of Dollars in Asset Sales, Enabling Stock Repurchase and Balance Sheet Deleveraging Ortelius Advisors, L.P. today issued the following open letter to stockholders of Surgery Partners, Inc. (NASDAQ:SGRY). March 10, 2026 Fellow Stockholders, Ortelius Advisors, L.P. ("Ortelius" or "we") believes that Surgery Partners, Inc. ("Surgery" or the "Company") has significant upside potential, based on its high-quality assets, favorab
BRENTWOOD, Tenn., March 09, 2026 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), is scheduled to meet with investors at the Barclays 28th Annual Global Healthcare Conference, including a presentation on Tuesday, March 10, 2026, at 2:30 p.m. (Eastern Time). Interested investors and other parties may listen to a simultaneous webcast of the event through the investor relations section of the company's website at www.surgerypartners.com. The replay will also be available on this same website for a limited time following the call. To learn more about Surgery Partners, please visit the Company's website at www.surgerypartners.com. Surgery Partner
SCHEDULE 13G/A - Surgery Partners, Inc. (0001638833) (Subject)
10-K - Surgery Partners, Inc. (0001638833) (Filer)
8-K - Surgery Partners, Inc. (0001638833) (Filer)
Analyst resumed coverage of Surgery Partners with a rating of Neutral and set a new price target of $27.00
BofA Securities resumed coverage of Surgery Partners with a rating of Buy and set a new price target of $28.00
BofA Securities initiated coverage of Surgery Partners with a rating of Buy and set a new price target of $30.00
Surgery Board and Management Team Have Presided Over the Vast Destruction of Value and Must Be Held Accountable Letter Outlines Multiple Paths to Building and Unlocking Intrinsic Value for Stockholders Divestiture of Surgical Hospitals Should Generate Billions of Dollars in Asset Sales, Enabling Stock Repurchase and Balance Sheet Deleveraging Ortelius Advisors, L.P. today issued the following open letter to stockholders of Surgery Partners, Inc. (NASDAQ:SGRY). March 10, 2026 Fellow Stockholders, Ortelius Advisors, L.P. ("Ortelius" or "we") believes that Surgery Partners, Inc. ("Surgery" or the "Company") has significant upside potential, based on its high-quality assets, favorab
BRENTWOOD, Tenn., March 02, 2026 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, today announced results for the fourth quarter and full year ended December 31, 2025. Fourth Quarter and Full Year 2025 Financial Highlights (All comparisons are year-over-year unless otherwise noted) Revenue increased 2.4% for the fourth quarter and 6.2% for the full year Same-facility revenues increased 3.5% for the fourth quarter and 4.9% for the full year Surgical cases decreased 2.1% for the fourth quarter and increased 2.0% for the full year Same-facility cases increased 1.3% for the fourth
BRENTWOOD, Tenn., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, announced the Company will release its fourth quarter 2025 results after market close on Monday, March 2, 2026, to be followed by a conference call on Tuesday, March 3, 2026 at 8:30 a.m. (Eastern Time). You can join the call as follows: Dial in number for live access: 1-877-451-6152 (domestic), 1-201-389-0879 (international)Replay (available 3 hours after the call and available until March 17, 2026): 1-844-512-2921 (domestic), 1-412-317-6671 (international)Passcode for the live call and the replay: 13758
BRENTWOOD, Tenn., March 12, 2026 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company") recently announced that Lloyd Dean has been appointed to serve as an independent director on its Board of Directors. Mr. Dean is the former Chief Executive Officer of CommonSpirit Health, one of the largest nonprofit health systems in the United States, with 142 hospitals, over 1,000 care sites, 25,000 physicians, and 150,000 employees across 21 states. From 2019 to 2022, he led the formation and integration of CommonSpirit, advancing clinical quality, operational performance, and community health initiatives at national scale. Prior to CommonSpirit, Mr. Dean ser
BRENTWOOD, Tenn., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company") today announced that Dr. Laura L. Forese has been appointed to serve as an independent director on its Board of Directors. Dr. Forese's appointment, which is effective January 10, 2025, will increase the size of Surgery Partners' Board to eleven members. Dr. Forese joins the Surgery Partners Board with extensive healthcare experience. Her career in healthcare administration spans over 40 years, most recently serving as an executive vice president and chief operating officer for New York-Presbyterian, one of the nation's most comprehensive, integrated academic heal
PURCHASE, NY, Sept. 20, 2023 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in whole-person virtual care, today appointed Eric Evans to the company's board of directors. Mr. Evans, currently chief executive officer and director of Brentwood, TN-based Surgery Partners, Inc. (NASDAQ:SGRY), is a recognized healthcare and hospital executive with significant experience leading complex organizations operating at the intersection of care and technology. Mr. Evans joins the board following the retirement of Senator William Frist, M.D. earlier this year, and will serve on the board's compensation committee. David B. Snow, Jr., non-executive Chairman of the company's board,
SC 13G/A - Surgery Partners, Inc. (0001638833) (Subject)
SC 13G - Surgery Partners, Inc. (0001638833) (Subject)
SC 13G/A - Surgery Partners, Inc. (0001638833) (Subject)